EMEA-001768-PIP02-15-M03

Key facts

Invented name
Varuby
Active substance
rolapitant
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0194/2020
PIP number
EMEA-001768-PIP02-15-M03
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral dosage form
Condition(s) / indication(s)
Prevention of nausea and vomiting
Route(s) of administration
Oral use
Contact for public enquiries
Tesaro Bio Netherlands B.V.

Tel. +41 415880618
E-mail: lenerose.x.arfelt@gsk.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating